KLK4 and ovarian cancer: Elevated expression of KLK4, KLK5, KLK6, and KLK7 are linked to multi-cellular aggregation of ovarian cancer cells and non-responsiveness of patients to paclitaxel [21,22,23,24,25,26,27].